evaluations of her 2 children, a daughter and son. Evaluation of medical records was performed after informed consent of the legal next-of-kin and under the ethical guidelines of the Mayo Clinic Institutional Review Board. The prospective studies on the son and daughter included collection of clinical and family histories, physical and neurologic examinations, routine laboratory studies, neuropsychologic testing, and magnetic resonance imaging (MRI) of the brain.
Neuropathologic Methods
Archival pathologic material from the autopsy of the mother was reviewed and a more detailed neuropathologic study was performed on the brain of the daughter. Archival glass slides from the mother had been stained with hematoxylin and eosin (H&E) and a few with Bielschowsky silver stains. Available were sections from cerebral cortex, hippocampus, amygdala, basal ganglia, substantia nigra, medulla, and cerebellum. Subsequently, some of the slides were decolorized and used for immunohistochemistry for pan-Ab (monoclonal antibody 13.3.3; 1:5000; Todd Golde, Mayo Clinic) and phosphotau (CP13, 1:1000; Peter Davies, Albert Einstein College of Medicine) using standard laboratory methods and a DAKO Autostainer with Envision detection system. The section of medulla was decolorized and restained with immunohistochemistry for human leukocyte antigen (HLA)-DR (LN-3, 1:100; ICN Biologicals, Lisle, IL) to detect activated microglia and macrophages and counterstained with Luxol fast blue to assess myelin integrity.
Gross examination and sampling of the daughter's brain followed a systematic and standardized dissection protocol, including sampling from 6 regions of neocortex, anterior and posterior hippocampus, basal forebrain with amygdala, basal ganglia, thalamus, midbrain, pons, medulla, cervicomedullary junction, cerebellum, and olfactory bulb. Dissected samples were embedded in paraffin and 5-mm thick sections were examined with H&E. Sections of cortex, hippocampus, basal forebrain, basal ganglia, and cerebellum were studied with thioflavin-S fluorescent microscopy. A section of the amygdala was immunostained for a-synuclein (polyclonal antibody NACP; 1:3000; Mayo Clinic Jacksonville). Additional cortical and brainstem sections were not stained for a-synuclein as the amygdala had no Lewy bodies or Lewy neuritis. Previous studies of a large number of AD cases have shown that when Lewy bodies are not detected in the amygdala, they are also absent in brainstem and cortex. 20 Moreover, ubiquitin (Ubi-1; 1:5000; Encor Biotechnology, Alachua, FL) immunohistochemistry of cortex, midbrain, medulla, and cervicomedullary junction did not reveal any Lewy bodies. Sections of motor cortex, midbrain, medulla, and spinal cord were stained with Luxol fast blue, HLA-DR, and ubiquitin. Sections of cortex, hippocampus, and basal forebrain were also studied with the Bielschowsky silver stain. Adjacent sections of cortex, hippocampus, and cerebellum were immunostained for Ab40 and Ab42 (monoclonal antibodies 13.1.1 and 4.1.3; 1:000, after formic acid pretreatment; both antibodies from Todd Golde, Mayo Clinic, Jacksonville). A section of hippocampus was immunostained for TDP-43 (polyclonal; 1:3000, ProteinTech, Chicago, IL) according to a published protocol. 21 
Genetic Methods
Genetic analysis was performed on DNA extracted from blood cells from both the son and daughter with polymerase chain reaction (PCR) and primers spanning all exons of PSEN1 as previously described. 12, 22 The PCR products were sequenced using fluorescent dye-terminator chemistry in both directions according the manufacture directions (Applied Biosystems Inc, Foster City, CA).
RESULTS

Clinical History of the Mother
A white woman, with 2 children, developed first signs of cognitive impairment in her early 30s. This woman was adopted hence it is not possible to determine if the mutation she carried was spontaneous or inherited. Both of her children had a similar disorder. She presented with impaired memory, and over a 3-year period experienced gradual worsening of her intellectual facilities, such that she could no longer participate in her former activities, prepare meals, or perform housework. She developed a seizure disorder 4 years before her death. Laboratory studies were within normal limits, and a brain biopsy showed changes consistent with AD. After 8 years of illness she died at 40-years-of-age. A complete autopsy was performed at an outside medical facility according to standard medical procedures and after consent from the legal next-of-kin.
Clinical History of the Daughter
The patient's daughter presented with memory problems that began at 32-years-of-age. She often repeated questions, forgot details of recent conversations and events, and routinely forgot to complete tasks assigned to her at work. At 35-years-of-age, her Mini-Mental Status Examination 23 (MMSE) score was 18 of 30. Neuropsychometric testing revealed a Mattis Dementia Rating Scale 24 score of 109 of 144, indicating generalized cognitive difficulties. Moderate to severe impairment was seen in tests of divided attention, mental arithmetic, learning efficiency, and recognition memory. Overall, she demonstrated a significant amnestic disturbance with impairment in learning, retaining new information, problem-solving skills, and divided attention. Immediate attention, vocabulary, and visuospatial skills were intact. MRI of the brain showed multiple small cerebral white matter lesions in the centrum semiovale and the periventricular white matter on T2 images consistent with small vessel disease.
When she was evaluated at 37-years-of-age, she had prominent dysarthria, gait unsteadiness, and agitation. She also had developed generalized tonic-clonic seizures. Her MMSE score had decreased to 10. Neurologic examination revealed spastic dysarthria, spastic gait, and symmetrical brisk reflexes in the biceps, triceps, brachioradialis, quadriceps, and gastrocnemius tendons. She also had a hyperactive jaw jerk and positive Hoffman signs. Four months later, she died and an autopsy limited to evaluation of the brain was performed.
Clinical History of the Son
The patient's son presented with memory difficulties that began at 33-years-of-age. He had 18 years of formal education, including a Masters in Business Administration, and he had previously worked as a marketing manager. At 40-years-of-age he reported increasing difficulty at work, noting impairment in the speed of thought processing, calculating, concentration, shortterm memory, and learning new information. He began to misplace objects, had trouble remembering names of people, and needed to take extensive notes as reminders to allow him to complete his work. He would repeatedly ask the same questions. He had no symptoms of depression, delusions, or hallucinations. He developed dysarthria and balance difficulties, falling on a few occasions, and he reported gait unsteadiness when walking on uneven ground. He did not have impairment in basic activities of daily living, but he no longer drove a motor vehicle. He took donepezil and memantine.
His neurologic examination at 40-years-of-age revealed mild dysarthria, decreased rapid alternating movements on the left, mild difficulty with tandem gait, and a MMSE of 24, with 0 of 3 on memory items. Neurologic examination at 45-years-of-age was notable for a MMSE score of 22, with 6 of 10 on orientation and 0 of 3 on memory items. He had mild spastic dysarthria with decreased mouth rapid alternating movements for labials, linguals, and palatals. He had brisk reflexes (legs more than arms) and mild spasticity in his legs. He walked with a mildly spastic, wide-based gait. Plantar responses were flexor on both sides, and there was no clonus. Fasciculations were absent. A jaw jerk reflex was present. He was able to do tandem gait with mild difficulty.
At 40-years-of-age his MRI, electroencephalogram, and laboratory tests were unremarkable. Repeat MRI of the brain at 45-years-of-age showed mild generalized atrophy, mild periventricular hyperintensities on T2 images consistent with small vessel disease, and bilateral (left more than right) enlargement of the temporal horns of the lateral ventricles seen on T1 images. There was left greater than right hippocampal atrophy ( Fig. 1A ).
Neuropathologic Findings of the Mother
The autopsy report and archival pathologic material were available for review on the mother. The autopsy had been performed 22 years before and only glass slides were available, the paraffin blocks having been discarded. The autopsy report described marked cortical atrophy, especially in the frontal regions, and marked loss of pigmentation of the substantia nigra. The ventricles were moderately enlarged, and the basal ganglia and thalamus were reported to be atrophic.
Sections of the cortex showed severe atrophy with marked neuronal loss, gliosis, and status spongiosis. The cerebral white matter showed rarefaction with myelinated fiber loss and gliosis. Sections of cortex, hippocampus, and basal ganglia showed numerous senile plaques and neurofibrillary tangles consistent with advanced AD ( Fig. 2A) . The Braak neurofibrillary tangle stage was consistent with stage VI. The senile plaques showed a range of morphologic features, including diffuse plaques and plaques with dense amyloid cores. There was mild amyloid angiopathy in leptomeninges ( Fig. 2B ). Many of the senile plaques had neuritic elements, and there were numerous neuropil threads, especially with tau immunohistochemistry (Figs. 2C, D). The substantia nigra had 
Neuropathologic Findings of the Daughter
An autopsy limited to evaluation of the brain was performed on the daughter after consent from the legal next-of-kin. The brain was divided in the sagittal plane with the right half frozen for biochemical and genetic studies and the left half fixed in formalin for histologic studies. The calculated weight of the whole brain based upon the weight of the left half (510 g) was 1020 g. (The normal brain weight for adult women ranges from 1300 to 1100 g.) There was mild cortical atrophy in superior frontal, inferior parietal, and inferomedial temporal lobes. Coronal sections showed mild ventricular enlargement, particularly of the temporal horn of the lateral ventricle (Fig. 1B) . Subcortical, brainstem, and cerebellar structures were grossly unremarkable.
Microscopic examination of the neocortex revealed pathology that was less severe than her mother. There was minimal thinning of the cortical ribbon with focal gliosis and mild microvacuolation, usually associated with senile plaques, many of which were readily apparent on H&E because of dense amyloid cores (Fig. 4A ). There were also many neuritic plaques ( Fig. 4B ) and numerous neurofibrillary tangles in the cortex, hippocampus (Fig. 4C) , and basal nucleus of Meynert (Fig. 4D ). The basal ganglia had many amyloid plaques, including neuritic type plaques and plaques with dense amyloid cores (Figs. 5A, B ). There were also neurofibrillary tangles in the striatum. The Braak neurofibrillary tangle stage was consistent with stage VI. There was mild focal amyloid angiopathy of the leptomeningeal vessels, but no significant arteriosclerotic vasculopathy. Both the hippocampus and entorhinal cortex had neuronal loss and gliosis. The substantia nigra had mild focal neuronal loss and neurofibrillary tangles, but no Lewy bodies. The cerebellum did not have significant Purkinje cell loss or Bergmann gliosis, but there were many diffuse amyloid deposits in the molecular layer. The amyloid deposits were mostly composed of Ab42 with less Ab40 (Fig. 6 ), especially diffuse amyloid plaques in cortex (Fig. 6A) , hippocampus (Fig. 6B) , and cerebellum (Fig. 6E ). Amyloid in blood vessels and in plaques with dense amyloid cores had Ab40 immunoreactivity (Figs. 6D, F). A range of plaque types is detected in the brain of the mother, including some plaques with a so-called cotton wool appearance (A). Immunostaining for Ab (B) shows mostly diffuse amyloid deposits, and mild focal amyloid angiopathy (inset). A Bielschowsky stain (C) shows neuritic elements in many of the plaques, and many cortical neurofibrillary tangles (inset). The tau immunostain (C) shows dystrophic neurites in plaques, but also profusely throughout the cortical gray matter. (A-D, Â 400). A and B) were readily apparent on routine hematoxylin and eosin stains owing to dense amyloid cores (arrows in A). The Bielschowsky stain shows prominent neuritic elements in many of the senile plaques (B). Inset shows higher magnification of a neuritic plaque. In the hippocampus (C), there are many neuritic plaques and flame-shaped neurofibrillary tangles. In the basal nucleus of Meynert (D), there are many globose neurofibrillary tangles (arrows) with Bielschowsky stain. The corticospinal tract showed mild degeneration, with mild rarefaction of the subcortical white matter beneath the motor cortex, as well as pallor and myelin vacuolation in the cerebral peduncles and medullary pyramid. The changes were less severe than in her mother, and were best appreciated by immunohistochemistry for activated microglia with HLA-DR (Fig. 7B) . In contrast to the microgliosis in the corticospinal tract, there was no neuronal loss or microglial activation in the motor cortex ( Fig. 7A ) or in the hypoglossal nucleus (Figs. 7C, D) . Immunohistochemistry for TDP-43, a marker for motor neuron disease, 25 was negative. 
Genetic Analyses of the Son and Daughter
PCR analysis of DNA from the son and daughter revealed a point mutation at codon 135 of PSEN1 in the second transmembrane spanning domain, causing a change in the amino acid residue from asparagine to serine (N135S mutation). The codon is located at the beginning of the second transmembrane domain (Fig. 8) . The mutation creates a DdeI restriction site, which was used to confirm the presence of the mutation in a separate PCR reaction.
DISCUSSION
We evaluated a woman and her 2 children who had dementia beginning in their 30s. Notably, both children had an unusual phenotype for AD, with prominent spastic dysarthria and limb spasticity. Furthermore, the mother and daughter had seizures. The children were followed prospectively and had documented cognitive deficits in multiple domains, including memory, language, and attention on formal neuropsychologic tests. The autopsy findings in the mother and daughter were those of AD and characterized by widespread neurofibrillary tangles and neuritic plaques, as well as mild amyloid angiopathy. Although there were a few plaques that had the morphology of so-called cotton wool plaques, 18 which have been described in EOFAD owing to PSEN1 mutations associated with spastic paraparesis, 10, 13, 15, 17 most of the senile plaques had prominent neuritic elements and dense amyloid cores, features that are absent in cotton wool plaques. The specificity of cotton wool plaques for PSEN1 mutations is not absolute, as they can be occasionally detected in sporadic AD. 26 Moreover, EOFAD with extensive cotton wool plaques do not always have spastic paraparesis. 22 In a review of the pathology of a large series of brains from patients with PSEN1 mutations, Mann and coworkers 27 noted that there were 2 major types of amyloid deposition-one associated with deposits that had mostly Ab42 immunoreactivity and the other with deposits showing almost equal Ab40 and Ab42 immunoreactivity as well as severe amyloid angiopathy. In type 1, many of the plaques in the cortex and especially the cerebellum are diffuse amyloid deposits, as in this case. The pathology in the present kindred is consistent with type 1, which was most often found in mutations in the amino-terminal half of presenilin, 27 as in this case.
Although the 2 children had documented spasticity and gait difficulties, this was not documented in the mother. Nevertheless, corticospinal tract pathology was detected in both the mother and her daughter, and the changes were actually more marked in the mother. Given the absence of clinical features in the mother, it raises the possibility that the observed changes in the pyramids may not be directly related to the observed long tract signs. It is also possible that long tract signs were present in the mother, but never documented given her severe cognitive problems. It is worth noting that only a few autopsy studies have documented corticospinal tract degeneration in EOFAD associated with spastic paraparesis, 18 and that when it is detected the pathogenesis of tract degeneration is uncertain. It has been suggested that tract degeneration is linked to severe motor cortex pathology 18 or to white matter pathology secondary to severe amyloid angiopathy. 28 The motor cortex was not available for study in the mother. In the daughter, the motor cortex had many senile plaques and neurofibrillary tangles, but no significant atrophy and relatively well preserved Betz cells. In neither the mother nor the daughter was there severe amyloid angiopathy. There was severe leukoencephalopathy in the mother in a distribution that paralleled cortical atrophy. The spinal cord was not available in either, but lower motor neurons in the hypoglossal nucleus were well preserved and there was no TDP-43 immunoreactivity. These findings argue against concurrent motor neuron disease as a cause of the tract degeneration and genetic evidence that has failed to identify variants in genes known to produce familial spastic paraparesis in EOFAD with spastic paraparesis. 29 This study is the first to demonstrate autopsyconfirmed AD and corticospinal tract degeneration in EOFAD with spastic paraparesis and seizures owing to N135S mutation in PSEN1. A single family with this mutation has been previously reported, but there is no description of postmortem pathology in this family and only limited clinical information reported. 19 In a multicenter survey of PSEN1, a novel Greek mutation was discovered in a family whose affected members presented with memory loss in their early-to-mid 30s and death from the disease in their early 40s. 19 Limb spasticity was reported in one family member and seizures in other. The clinical findings in our patients were similar to those reported in the Greek kindred, although spastic dysarthria was not mentioned in the Greek family.
The clinical diagnosis of AD in the setting of early onset dementia with atypical clinical features, such as spasticity and spastic dysarthria is challenging. Differentiating AD from one of the other disorders that can produce spastic paraparesis, such as frontal lobe degenerations, 30 motor neuron disorders, 31 hereditary vascular dementias, 32 prion disorders, 33 and other amyloidoses, 34 requires clinical acumen as well as ancillary tests, including imaging and genetic testing. 35 It recently has become possible to detect amyloid deposits in vivo with positron emission tomography, and these studies show early amyloid deposits in the basal ganglia in PSEN1 mutation carriers. 36 It is thus of interest that the basal ganglia in the daughter also had many plaques and tangles. The most common genetic basis of autosomal dominant early onset dementia is linkage to chromosome 14 or presence of mutations in PSEN1. 37 Clinical heterogeneity is the rule in early onset dementia. In a review of very early onset AD, Snider and coworkers 38 reported on a range of additional clinical features, including aphasia, seizures, pyramidal signs, and parkinsonism. Similarly, in the large pathologic series reported by Mann and coworkers 27 a similar spectrum of clinical features were noted in EOFAD owing to PSEN1 mutations.
The significance of mutation at codon 135 is that it is a residue that is shared by both PSEN1 and PSEN2 and, like other pathogenic mutations at codons 139, 143, and 147, is located within the transmembrane domain aligning on one face of an a helix ( Fig. 6 ). 39 This makes it likely that the g-secretase activity is affected by this mutation.
